Welcome Back

Google icon Sign in with Google
OR
I agree to abide by Pharmadaily Terms of Service and its Privacy Policy

Create Account

Google icon Sign up with Google
OR
By signing up, you agree to our Terms of Service and Privacy Policy
Instagram
youtube
Facebook

Oncology - Car-T - Cra Ii

Fortrea
Fortrea
1-3+ years
$105,000 – $117,000 annually
Remote, USA, Remote
10 Feb. 14, 2026
Job Description
Job Type: Full Time Education: B.Sc./ M.Sc./ M.Pharm/ B.Pharm/ Life Sciences Skills: Causality Assessment, Clinical SAS Programming, Communication Skills, CPC Certified, GCP guidelines, ICD-10 CM Codes, CPT-Codes, HCPCS Codes, ICD-10 CM, CPT, HCPCS Coding, ICH guidelines, ICSR Case Processing, Interpersonal Skill, Labelling Assessment, MedDRA Coding, Medical Billing, Medical Coding, Medical Terminology, Narrative Writing, Research & Development, Technical Skill, Triage of ICSRs, WHO DD Coding

Job Title: Clinical Research Associate II (CRA II) – Oncology / CAR-T | Remote U.S.

Location: Remote – United States (Available in 15 U.S. Hub Locations)
Job Category: Clinical Research / Clinical Operations
Employment Type: Full-Time (Full Service Outsourcing Model)
Experience Required: 1–3+ years of clinical monitoring experience (Oncology required; CAR-T preferred)
Travel Requirement: 60–70% travel | 8–10 Days On-Site (DOS) per month
Compensation: Target Pay Range: $105,000 – $117,000 annually
Application Status: Open – Applications accepted on an ongoing basis

About the Organization

Join Fortrea, a leading global Contract Research Organization (CRO) delivering end-to-end clinical development and technology solutions across more than 20 therapeutic areas. Operating in approximately 100 countries, Fortrea partners with pharmaceutical and biotechnology innovators to accelerate the development of advanced therapies, including oncology and cell and gene treatments.

Through its Full Service Outsourcing (FSO) model, Fortrea provides embedded clinical expertise and operational excellence across complex therapeutic programs.

Position Overview

Fortrea is seeking experienced Clinical Research Associate II (CRA II) professionals with oncology expertise to support oncology and CAR-T clinical trials across the United States. This role is ideal for CRAs with experience in hematologic malignancies, solid tumors, or advanced cell therapies who are ready to contribute to high-impact oncology programs.

The CRA II will be responsible for comprehensive site monitoring, regulatory compliance, patient safety oversight, and data integrity within oncology trials, including complex CAR-T studies where applicable.

Key Responsibilities

  • Conduct pre-study, site initiation (SIV), routine monitoring (RMV), and close-out visits (COV)

  • Ensure study sites operate in compliance with ICH-GCP, FDA regulations, sponsor requirements, and protocol specifications

  • Verify informed consent procedures and patient protection standards

  • Perform detailed source document review and ensure accurate Case Report Form (CRF) completion

  • Identify missing, inconsistent, or implausible data and manage query resolution in electronic data capture (EDC) systems

  • Oversee Serious Adverse Event (SAE) reporting, including documentation, narrative preparation, and follow-up

  • Manage registry activities and perform site feasibility assessments as required

  • Maintain essential regulatory documentation and ensure audit readiness

  • Liaise with vendors, sponsors, and cross-functional study teams

  • Support co-monitoring and onboarding of new CRAs

  • Serve as Local Project Coordinator or primary site contact when assigned

Required Qualifications

  • University or college degree in life sciences, healthcare, or related discipline; or certification in an allied health profession (e.g., nursing licensure) from an accredited institution

  • 1–3+ years of independent clinical monitoring experience

  • Oncology clinical trial experience required

  • CAR-T or cell and gene therapy experience preferred

  • Strong understanding of ICH-GCP, FDA regulations, and oncology trial complexities

  • Ability to travel 60–70% with 8–10 DOS per month

  • Strong organizational, communication, and stakeholder management skills

Preferred Competencies

  • Experience in hematology/oncology trials or advanced biologics

  • Knowledge of oncology safety reporting requirements

  • Experience working within Full Service Outsourcing (FSO) or embedded sponsor models

  • Proficiency in electronic clinical trial management systems

Work Environment

  • Remote/home-based position within the United States

  • Frequent domestic travel to investigative sites; occasional international travel may be required

  • Office-based work involving electronic systems and regulatory documentation

  • High-performance, compliance-driven environment

Physical Requirements

  • Ability to sit for extended periods and operate a vehicle safely

  • Frequent computer use with repetitive hand and wrist movements

  • Occasional bending, stooping, and lifting (15–20 lbs, including laptop and travel equipment)

  • Flexibility to work varied hours based on study demands

Compensation and Benefits

Eligible employees working 20 or more hours per week receive comprehensive benefits, including:

  • Medical, Dental, and Vision Insurance

  • Life Insurance and Short-Term/Long-Term Disability coverage

  • 401(k) Retirement Plan

  • Paid Time Off (PTO) – Flex Plan

  • Employee Recognition Programs

  • Employee Resource Groups (ERGs)

Why Join Fortrea

Fortrea is committed to advancing oncology innovation and accelerating access to transformative therapies such as CAR-T and other cell and gene treatments. As a CRA II in Oncology, you will play a critical role in ensuring patient safety, regulatory compliance, and high-quality data across cutting-edge oncology programs.

This opportunity offers therapeutic specialization, career progression, and involvement in complex oncology trials that directly impact patient outcomes.

Apply now through ThePharmaDaily.com to advance your career in oncology clinical research and contribute to the future of cancer treatment.